Catheter Ablation of Accessory Atrioventricular Pathways (Wolff–Parkinson–White Syndrome) by Radiofrequency Current

FOR more than 20 years, surgical ablation of the accessory pathway has served as definitive therapy for patients with the Wolff—Parkinson—White syndrome. 1 2 3 The successful introduction of percutaneous catheter ablation of the atrioventricular junction in 1982 4 , 5 stimulated interest in nonsurgi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 1991-06, Vol.324 (23), p.1605-1611
Hauptverfasser: Jackman, Warren M, Wang, Xunzhang, Friday, Karen J, Roman, Carlos A, Moulton, Kriech P, Beckman, Karen J, McClelland, James H, Twidale, Nicholas, Hazlitt, H. Andrew, Prior, Michael I, Margolis, P. David, Calame, James D, Overholt, Edward D, Lazzara, Ralph
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FOR more than 20 years, surgical ablation of the accessory pathway has served as definitive therapy for patients with the Wolff—Parkinson—White syndrome. 1 2 3 The successful introduction of percutaneous catheter ablation of the atrioventricular junction in 1982 4 , 5 stimulated interest in nonsurgical ablation of accessory atrioventricular pathways. 6 7 8 9 10 11 Initial approaches used, with moderate success, high-energy direct-current shocks delivered near the coronary-sinus ostium to ablate posteroseptal pathways 12 13 14 and to the endocardial surface of the tricuspid annulus to ablate right—free-wall pathways. 15 16 17 High-energy shocks were also applied, with very limited success, within the coronary sinus to ablate left—free-wall accessory pathways. 18 Warin and coworkers successfully ablated 94 percent . . .
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJM199106063242301